The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Hyponatremia Associated with Selective Serotonin-Reuptake Inhibitors in Older Adults
Abstract
Objective: To review the incidence, risk factors, mechanism, times of onset and resolution, and treatment of hyponatremia associated with selective serotonin-reuptake inhibitors (SSRIs). Data Sources: An English-language literature search was conducted using MEDLINE (1966–December 2005) using the search terms selective serotonin-reuptake inhibitor, hyponatremia, syndrome of inappropriate secretion of antidiuretic hormone, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline. Additional references were identified by reviewing bibliographies of articles retrieved. Study Selection and Data Extraction: Relevant data were extracted from published reports, letters, and studies of humans with hyponatremia and/or syndrome of inappropriate secretion of antidiuretic hormone (SIADH) secondary to SSRIs. All articles identified from data sources were reviewed for relevant information. Applicable information was included in this review. Data Synthesis: Numerous case reports, observational studies, and case-controlled studies, as well as one prospective clinical trial, have reported hyponatremia associated with SSRI use, with the incidence varying from 0.5% to 32%. Risk factors for the development of hyponatremia with SSRIs include older age, female gender, concomitant use of diuretics, low body weight, and lower baseline serum sodium concentration. In published reports, hyponatremia developed within the first few weeks of treatment and resolved within 2 weeks after therapy was discontinued. The mechanism by which SSRIs cause hyponatremia is thought to be secondary to development of SIADH. Treatment of isovolemia hypotonic hyponatremia associated with SSRI use includes water restriction and mild diuresis with a loop diuretic. More severe cases may be treated with higher doses of loop diuretics and hypertonic saline. There have been few reports of rechallenge with the same or another SSRI or substitution of another agent from a different therapeutic class. In some, but not all, cases hyponatremia recurred. Conclusions: Practitioners should be on the alert for this potentially life-threatening adverse event, especially in older adults with other risk factors for developing hyponatremia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A double‐blind, placebo‐controlled trial
Pinals, R. S., Kaplan, S. B., Lawson, J. G., & Hepburn, B. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291202 · Cited by 1,355
Goldfrank's Toxicologic Emergencies.
(1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-2-323 · Cited by 1,278
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
Rosenbaum, J. F., Fava, M., Hoog, S. L., Ascroft, R. C., & Krebs, W. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00126-7 · Cited by 574
Goldfrank's Toxicologic Emergencies.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-821_6 · Cited by 478
Treatment of electrolyte disorders in adult patients in the intensive care unit
Kraft, M. D., Btaiche, I. F., Sacks, G. S., & Kudsk, K. A. (2005) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp040300 · Cited by 454
Similar Effectiveness of Paroxetine, Fluoxetine, and Sertraline in Primary Care: A Randomized Trial
Kroenke, K., West, S. L., Swindle, R., Gilsenan, A., Eckert, G. J., Dolor, R., Stang, P., Zhou, X.-H., Hays, R., & Weinberger, M. (2001) · JAMA · doi:10.1001/jama.286.23.2947 · Cited by 312
Treatment of the serotonin syndrome with cyproheptadine
Graudins, A., Stearman, A., & Chan, B. (1998) · The Journal of Emergency Medicine · doi:10.1016/s0736-4679(98)00057-2 · Cited by 300
Liu, B. A., Mittmann, N., Knowles, S. R., & Shear, N. H. (1996) · Europe PMC (PubMed Central) · Cited by 290
Wilkinson, T. J., Begg, E. J., Winter, A. C., & Sainsbury, R. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00872.x · Cited by 188
Michelson, D., Fava, M., Amsterdam, J., Apter, J., Londborg, P., Tamura, R., & Tepner, R. G. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.4.363 · Cited by 181
Treatment of the Serotonin Syndrome with Cyproheptadine
Lappin, R. I., & Auchincloss, E. L. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410133311514 · Cited by 152
Selemon, L. D., Goldman, P. S., & Tamminga, C. A. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.1.5 · Cited by 150
Kirby, D., Harrigan, S., & Ames, D. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.591 · Cited by 149
Causes and Management of Hyponatremia
Palmer, B. F., Gates, J. R., & LADER, M. H. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d105 · Cited by 139
Paroxetine-Induced Hyponatremia in Older Adults: A 12-Week Prospective Study
Fabian, T. J., Amico, J. A., Kroboth, P. D., Mulsant, B. H., Corey, S. E., Begley, A. E., Bensasi, S., Weber, E., Dew, M. A., Reynolds, C. F., et al. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.3.327 · Cited by 129
Association between antidepressant drug use and hyponatraemia: a case‐control study
Movig, K. L. L., Leufkens, H. G. M., Lenderink, A. W., van den Akker, V. G. A., Hodiamont, P. P. G., Goldschmidt, H. M. J., & Egberts, T. C. G. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01550.x · Cited by 121
Probing the Safety of Medications in the Frail Elderly
Oslin, D. W., Have, T. R. T., Streim, J. E., Datto, C. J., Weintraub, D. A., DiFilippo, S. D., & Katz, I. R. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0804 · Cited by 115
Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine
Tate, J. L. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.3.399b · Cited by 114
The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT
Flint, A. J., & Rifat, S. L. (1998) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199801)13:1<12::aid-gps718>3.0.co;2-f · Cited by 93
Fluoxetine in Elderly Patients: Is There Cause for Concern?
Brymer, C., & Winograd, C. H. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb01987.x · Cited by 75
Rosner, M. H. (2004) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200402000-00012 · Cited by 70
Vasopressin Antagonists as Aquaretic Agents for the Treatment of Hyponatremia
Palm, C., Pistrosch, F., Herbrig, K., & Gross, P. A. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.05.014 · Cited by 63
Hyponatraemia Associated with the Use of Selective Serotonin Re-Uptake Inhibitors
Strachan, J., & Shepherd, J. (1998) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679809062743 · Cited by 52
Delayed Recurrent SIADH Associated with SSRIs
Arinzon, Z. H., Lehman, Y. A., Fidelman, Z. G., et al. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a337 · Cited by 52
Sertraline: A Review of its Use in the Management of Major Depressive Disorder in Elderly Patients
Muijsers, R. B. R., Plosker, G. L., & Noble, S. (2002) · Drugs & Aging · doi:10.2165/00002512-200219050-00006 · Cited by 51
SIADH associated with fluoxetine and sertraline therapy
Jackson, C. V., Carson, W. H., Markowitz, J., & Mintzer, J. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.5.809b · Cited by 47
Anorgasmia with the use of fluoxetine
Musher, J. S. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.7.948a · Cited by 44
Syndrome of Inappropriate Secretion of Antidiuretic Hormone Secondary to Fluoxetine
Blacksten, J. V., & Birt, J. A. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700609 · Cited by 39
Fisher, A., Davis, M., Croft‐Baker, J., Purcell, P. M., & McLean, A. J. (2002) · Adverse Drug Reactions and Toxicological Reviews · doi:10.1007/bf03256195 · Cited by 33
Severe symptomatic hyponatremia during citalopram therapy - a case report
Flores, G., Pérez-Patrigeón, S., Cobos-Ayala, C., et al. (2004) · BMC Nephrology · doi:10.1186/1471-2369-5-2 · Cited by 25
Druckenbrod, R. W., & Mulsant, B. H. (1994) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879400700412 · Cited by 25
Clinical pharmacology of serotonin-altering medications for decreasing alcohol consumption.
Naranjo, C. A., & Bremner, K. E. (1993) · PubMed · Cited by 24
Association of transient SIADH with sertraline
Doshi, D., & Borison, R. L. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.5.779b · Cited by 21
Recurrent hyponatremia associated with sertraline and lofepramine
Bouman, W. P., Johnson, H., Trescoli‐Serrano, C., & Jones, R. G. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.580a · Cited by 14
Cited by
Seppi, K., Weintraub, D., Coelho, M., Perez‐Lloret, S., Fox, S. H., Katzenschlager, R., Hametner, E., Poewe, W., Rascol, O., Goetz, C. G., et al. (2011) · Movement Disorders · doi:10.1002/mds.23884 · Cited by 1,141
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011) · BMJ · doi:10.1136/bmj.d4551 · Cited by 833
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
Metadata
- Authors
- Jacob, S., & Spinier, S. A.
- Venue
- Annals of Pharmacotherapy
- Publisher
- SAGE Publications
- Published
- 2006-09
- Volume
- 40
- Issue
- 9
- Pages
- 1618-1622
- ISSN
- 0012-6578 (ISSN-L)
- 1060-0280
- 1542-6270
- OpenAlex
- W2133527293
- Cited by
- 262
- References
- 34
- FWCI
- 13.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.